CANCER IMMUNOTHERAPIES BY DESIGN
LIVE

Serial Number

88918348

Owner

ITEOS THERAPEUTICS, INC

Attorney

Frances M. Jagla

First Use Date

Dec 19, 2011

Filing Date

May 15, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CANCER IMMUNOTHERAPIES BY DESIGN Trademark

Serial Number: 88918348 • Registration: 6215904

CANCER IMMUNOTHERAPIES BY DESIGN is a trademark filed by ITEOS THERAPEUTICS, INC on May 15, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ITEOS THERAPEUTICS, INC (3 trademarks)

Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

May 15, 2020

Registration Date

December 8, 2020

First Use Anywhere

December 19, 2011

First Use in Commerce

June 20, 2018

Published for Opposition

September 22, 2020

Goods & Services

Providing a website featuring information to patients and healthcare providers relating to oncological and autoimmune disorders

Scientific and medical research relating to oncological and autoimmune disorders

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 8, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Dec 8, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 22, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 22, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 2, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 20, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 20, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 20, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 20, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 20, 2020 CNEA
ASSIGNED TO EXAMINER
Aug 13, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 29, 2020 NWOS
NEW APPLICATION ENTERED
May 19, 2020 NWAP